MoneyWorks4Me

Aptus Pharma informs about updates on SAST

14 May 2026 Evaluate
Aptus Pharma has informed that it enclosed disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kripaliben Mayank Thakker.

The above information is a part of company’s filings submitted to BSE.
Peers